Author

F.-y. Luo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Huang· 2 shared A.-s. Jin· 2 shared B.-z. Liu· 2 shared J. Hu· 2 shared K. Wang· 2 shared L. Fang· 2 shared N. Tang· 2 shared P. Peng· 2 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Huang

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Reduced neutralization of SARS-CoV-2 B.1.617 variant by inactivated and RBD-subunit vaccine

J. Hu, X.-y. Wei, J. Xiang, P. Peng, F.-l. Xu, K. Wu, F.-y. Luo, A.-s. Jin, L. Fang, B.-z. Liu, K. Wang, N. Tang, A. Huang

The paper evaluates the neutralization efficacy of inactivated and RBD-subunit vaccines against SARS-CoV-2 B.1.617 and B.1.1.7 variants using a pseudovirus-based assay.

bioRxiv · Jul 9, 2021 · PreprintMicrobiology

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies

J. Hu, P. Peng, K. Wang, B.-z. Liu, L. Fang, F.-y. Luo, A.-s. Jin, N. Tang, A. Huang

This study evaluates the neutralization sensitivity of SARS-CoV-2 variants N501Y.V1 and N501Y.V2 to convalescent sera and monoclonal antibodies, finding reduced neutralization activity.

bioRxiv · Jan 22, 2021Microbiology